Literature DB >> 15788296

The prevalence and determinants of the use of complementary and alternative medicine in adult Turkish cancer patients.

Faruk Tas1, Zeki Ustuner, Gulbeyaz Can, Yesim Eralp, Hakan Camlica, Mert Basaran, Hakan Karagol, Burak Sakar, Rian Disci, Erkan Topuz.   

Abstract

A study was undertaken to analyze the extent of using complementary alternative medicine (CAM) and to compare sociodemographic and medical characteristics of users and non-users of CAM in Turkish oncology patients. A total of 615 patients with cancer who attended ambulatory patient care units answered the questionnaires. Medical information was reviewed from chart data. Some 291 patients (47.3%) had used at least one type of CAM since the time of initial diagnosis. CAMs almost always consisted of herbal agents (95%). Nettle (Urticae herba) used in conjunction with (88%) or without (56%) various herbal agents were the most popular and prominent CAMs used by patients. Univariate and multivariate comparisons of users and non-users of CAM were performed. In multivariate analysis, female sex (p=0.0006), high income (p=0.0008), advanced stage at diagnosis (p=0.02), and usage of multiple chemotherapy applications (p=0.03) were determined as independent factors for CAM use.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15788296     DOI: 10.1080/02841860510007549

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  12 in total

1.  Patients in Northwestern Turkey Prefer Herbs as Complementary Medicine after Breast Cancer Diagnosis.

Authors:  Bahadir M Gulluoglu; Asim Cingi; Tebessum Cakir; Afsar Barlas
Journal:  Breast Care (Basel)       Date:  2008-08-11       Impact factor: 2.860

2.  The view of patients with Choronic Obstructive Pulmonary Disease (COPD) on Complementary and Alternative Medicine (CAM) in Eastern Turkey.

Authors:  Zümrüt Akgün Şahin; Mutlu Şahin
Journal:  Afr J Tradit Complement Altern Med       Date:  2013-05-16

3.  Complementary and alternative medicine usage in cancer patients in southeast of Turkey.

Authors:  Mehmet Kucukoner; Zulfikar Bilge; Abdurrahman Isıkdogan; M Ali Kaplan; Ali Inal; Zuhat Urakci
Journal:  Afr J Tradit Complement Altern Med       Date:  2012-10-01

Review 4.  Complementary and alternative medicine (CAM) and supportive care in cancer: a synopsis of research perspectives and contributions by an interdisciplinary team.

Authors:  Anne Leis; Jennifer Millard
Journal:  Support Care Cancer       Date:  2007-07-17       Impact factor: 3.603

Review 5.  Prevalence of the Use of Herbal Medicines among Patients with Cancer: A Systematic Review and Meta-Analysis.

Authors:  John Baptist Asiimwe; Prakash B Nagendrappa; Esther C Atukunda; Mauda M Kamatenesi; Grace Nambozi; Casim U Tolo; Patrick E Ogwang; Ahmed M Sarki
Journal:  Evid Based Complement Alternat Med       Date:  2021-05-17       Impact factor: 2.650

6.  Use of chinese herb medicine in cancer patients: a survey in southwestern china.

Authors:  Tai-Guo Liu; Shao-Quan Xiong; Yan Yan; Hong Zhu; Cheng Yi
Journal:  Evid Based Complement Alternat Med       Date:  2012-09-11       Impact factor: 2.629

7.  Greco-arab and islamic herbal-derived anticancer modalities: from tradition to molecular mechanisms.

Authors:  Hilal Zaid; Michael Silbermann; Eran Ben-Arye; Bashar Saad
Journal:  Evid Based Complement Alternat Med       Date:  2011-11-22       Impact factor: 2.629

8.  Barriers to biomedical care and use of traditional medicines for treatment of cervical cancer: an exploratory qualitative study in northern Uganda.

Authors:  A D Mwaka; E S Okello; C G Orach
Journal:  Eur J Cancer Care (Engl)       Date:  2014-06-13       Impact factor: 2.520

9.  An Analysis of the Use of Complementary and Alternative Therapies in Patients with Breast Cancer.

Authors:  Oktay Tarhan; Ugur Muslu; Isil Somali; Cigdem Erten; Ahmet Alacacioglu; Sengul Varol; Leyla Aslan
Journal:  Breast Care (Basel)       Date:  2009-10-01       Impact factor: 2.860

10.  Use of complementary and alternative medicine by patients with hematological diseases experience at a university hospital in northeast Mexico.

Authors:  José Carlos Jaime-Pérez; Adrián Chapa-Rodríguez; Marisol Rodríguez-Martínez; Perla Rocío Colunga-Pedraza; Luis Javier Marfil-Rivera; David Gómez-Almaguer
Journal:  Rev Bras Hematol Hemoter       Date:  2012
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.